A recent report by KD market insights titled as " Europe Cancer Screening Market (2018–2023)" provides the key trends, opportunities and challenges market will face in the forecasted period of 6 years i.e. 2018-2023. The study also provides the Europe Cancer Screening Market.
Europe after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along with the rise in the number of cancer incidences is a key driving factor for the market. Western Europe is moving fast towards the adoption of performance-based remuneration systems.
Request for Sample @ https://www.kdmarketinsights.com/sample/3281
By end users, the market is segmented into hospitals, laboratories and independent physicians and clinics. The Laboratory segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 billion during the forecast period.
By screening type, the market is segmented into laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and endoscopy will be the leading segments during the forecast period 2018-2023.
By application type, the market can be segmented into lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023.
By countries, the market is divided into the United Kingdom (U.K.), France and Germany.
Key growth factors
Rise in the aging population, changing environmental conditions along with the adoption of a sedentary lifestyle is contributing to more cancer-related cases.
Threats and key players
Stringent regulations along with regulatory inter and intra state barriers pose many challenges for the region. Lack of associated funding and transparency in medical procedures turn out to be as threats to the market.
Key players in the European cancer screening market are F. Hoffman-La- Roche Ltd, Bayer AG, and Johnson & Johnson, Pfizer, Merck & co.
Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/europe-cancer-screening-market
Table Of Content@
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary
Chapter 2: Europe cancer screening market – market overview
2.1. Europe market overview – market trends, market attractiveness analysis, country-wise market revenue (USD)
2.2. Europe – market drivers and challenges
2.3. Value chain analysis – cancer screening market
2.4. Porter’s five forces analysis
2.5. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics)
2.5. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. d. Growth drivers and key challenges
2.6. Market segmentation based on type of screening (Laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
2.6. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. f. Growth drivers and key challenges
2.7. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
2.7. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. f. Growth drivers and key challenges
2.8. Major country penetration
Continue…@
Check for Discount@ https://www.kdmarketinsights.com/discount/3281
About KD Market Insights
KD Market Insights has come with the idea of helping business by intelligent decision making and thorough understanding of the industry. We offer a comprehensive database of syndicated research, customized reports as well as consulting services to help a business grow in their respective domain. At KD Market Insights, we offer our client a deep Market research reports accompanied by business consulting services that can help them to reach on top of the corporate world. Our customized reports are built by keeping all factors of the industry in mind.
Contact Us
150 State street, 3rd Floor,
Albany, New York
United states (12207)
Telephone: +1-518-300-1215
Email: - sales@kdmarketinsights.com
Website: - www.kdmarketinsights.com